Dexcom OverviewDexcom's common stock is $400K.
Get informed when a big investor buys or sells
+ Follow
Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
Dexcom (DXCM) currently reports a common stock of $400K as of June 2026. That compares with $400K in the prior-year period — up 0.0% year over year. Use the charts on this page to explore Dexcom's common stock history and peer comparisons.
Dexcom's common stock was unchanged from $400K to $400K — essentially flat versus a year earlier (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Dexcom reported $400K in common stock as of June 2026. That compares with $400K in the prior-year period — up 0.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current common stock of $400K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Dexcom, and consider following DXCM for alerts when major investors trade the stock.
Dexcom is classified in the Healthcare sector. On common stock, it currently shows $400K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DXCM with unrelated industries.
